The spinal cord stimulation devices market size has grown strongly in recent years. It will grow from $2.97 billion in 2025 to $3.23 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rise in chronic pain cases, failed back surgery syndrome prevalence, opioid alternative demand, neurology procedure growth, implantable device acceptance.
The spinal cord stimulation devices market size is expected to see strong growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to AI-driven stimulation algorithms, growth in wearable stimulators, expansion of pain management clinics, long-term pain therapy adoption, remote device monitoring. Major trends in the forecast period include personalized pain management therapy, rechargeable neurostimulation devices, minimally invasive neuromodulation, wireless programming systems, multi-lead stimulation technology.
The increasing prevalence of chronic pain is expected to propel the growth of the spinal cord stimulation (SCS) devices market. Chronic pain, characterized by persistent pain lasting 12 weeks or longer, often arises from conditions such as arthritis, neuropathy, or low back pain. This increase is driven by factors such as an aging population, lifestyle changes, chronic health conditions, and injuries or trauma. SCS devices help alleviate chronic pain by delivering electrical impulses to modify pain signals, offering relief for long-term conditions. For example, in November 2024, the Centers for Disease Control and Prevention (CDC) reported that in 2023, 24.3% of adults experienced chronic pain, with 8.5% reporting high-impact chronic pain, accounting for 34.9% of chronic pain cases. These trends underscore the rising demand for SCS devices in managing chronic pain effectively.
Major companies operating in the spinal cord stimulation devices market are increasingly emphasizing advanced technologies, such as AI-driven personalization, to enhance therapy responsiveness, enable adaptive pain control, and deliver more accurate, patient-specific treatment for individuals experiencing chronic pain. AI-driven spinal cord stimulation (SCS) systems utilize machine-learning models trained on device- and patient-generated data to adjust stimulation settings in near real time, with the goal of maintaining optimal pain relief while minimizing the programming workload for clinicians. For example, in September 2024, Nevro Corp., a US-based medical device company, introduced HFX iQ with HFX AdaptivAI, an AI-enabled SCS platform that leverages millions of data points and adaptive algorithms to personalize 10 kHz therapy and facilitate remote clinician monitoring. This platform is designed to automatically modify stimulation parameters based on individual patient responses, improving pain management outcomes and reducing the need for frequent in-person programming visits. By incorporating real-time insights and remote management capabilities, HFX iQ seeks to improve treatment precision, streamline clinical workflows, and deliver a more consistent and effective therapy experience for patients with chronic pain.
In November 2023, Boston Scientific Corporation strengthened its chronic pain treatment portfolio by acquiring Relevant Medsystems Inc. for $850 million. This acquisition added basivertebral nerve ablation therapy, provided by Relevant Medsystems, to Boston Scientific's suite of chronic pain solutions, which includes spinal cord stimulation devices. Relevant Medsystems, known for its innovative chronic pain management technologies, enhances Boston Scientific's ability to offer comprehensive treatment options for patients suffering from persistent pain.
Major companies operating in the spinal cord stimulation devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nevro Corp., Bluewind Medical, NeuroPace Inc., Vertos Medical Inc., SPR Therapeutics Inc., Saluda Medical Pty Ltd., Stimwave Technologies Inc., Nuvectra Inc., Soterix Medical Inc., Synapse Biomedical, ONWARD Medical NV, NeuroSigma Inc., Nalu Medical Inc., Neurostim Technologies, SpineX Inc., Aleva Neurotherapeutics SA, GTX Medical BV.
North America was the largest region in the spinal cord stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spinal cord stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the spinal cord stimulation devices market by increasing costs of electronic components, implantable leads, and battery systems. Implantable and rechargeable device segments are most affected, especially in North America and Europe. However, tariffs have encouraged domestic manufacturing, modular device designs, and supply chain diversification.
The spinal cord stimulation devices market research report is one of a series of new reports that provides spinal cord stimulation devices market statistics, including spinal cord stimulation devices industry global market size, regional shares, competitors with a spinal cord stimulation devices market share, detailed spinal cord stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the spinal cord stimulation devices industry. This spinal cord stimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Spinal cord stimulation (SCS) devices are implantable medical devices that help manage chronic pain by delivering gentle electrical pulses to the spinal cord. These pulses disrupt pain signals before they reach the brain, providing relief. SCS devices combine advanced neurotechnology with customizable programming, offering a minimally invasive treatment for conditions such as neuropathic pain and failed back surgery syndrome.
The primary types of SCS devices include implantable and non-implantable stimulators. Implantable spinal cord stimulators are surgically placed under the skin and deliver electrical pulses directly to the spinal cord, interfering with pain signals to alleviate chronic discomfort. SCS devices are further categorized into rechargeable and non-rechargeable types. They are used for various applications, including failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease, unsuccessful disk surgery, and other chronic pain conditions. End users include hospitals, ambulatory surgical centers, and neuro clinics.
The spinal cord stimulation devices market consists of sales of implantable pulse generators (IPGs), leads and electrodes, MRI-compatible SCS devices, and hybrid stimulation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The spinal cord stimulation devices market size is expected to see strong growth in the next few years. It will grow to $4.47 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to AI-driven stimulation algorithms, growth in wearable stimulators, expansion of pain management clinics, long-term pain therapy adoption, remote device monitoring. Major trends in the forecast period include personalized pain management therapy, rechargeable neurostimulation devices, minimally invasive neuromodulation, wireless programming systems, multi-lead stimulation technology.
The increasing prevalence of chronic pain is expected to propel the growth of the spinal cord stimulation (SCS) devices market. Chronic pain, characterized by persistent pain lasting 12 weeks or longer, often arises from conditions such as arthritis, neuropathy, or low back pain. This increase is driven by factors such as an aging population, lifestyle changes, chronic health conditions, and injuries or trauma. SCS devices help alleviate chronic pain by delivering electrical impulses to modify pain signals, offering relief for long-term conditions. For example, in November 2024, the Centers for Disease Control and Prevention (CDC) reported that in 2023, 24.3% of adults experienced chronic pain, with 8.5% reporting high-impact chronic pain, accounting for 34.9% of chronic pain cases. These trends underscore the rising demand for SCS devices in managing chronic pain effectively.
Major companies operating in the spinal cord stimulation devices market are increasingly emphasizing advanced technologies, such as AI-driven personalization, to enhance therapy responsiveness, enable adaptive pain control, and deliver more accurate, patient-specific treatment for individuals experiencing chronic pain. AI-driven spinal cord stimulation (SCS) systems utilize machine-learning models trained on device- and patient-generated data to adjust stimulation settings in near real time, with the goal of maintaining optimal pain relief while minimizing the programming workload for clinicians. For example, in September 2024, Nevro Corp., a US-based medical device company, introduced HFX iQ with HFX AdaptivAI, an AI-enabled SCS platform that leverages millions of data points and adaptive algorithms to personalize 10 kHz therapy and facilitate remote clinician monitoring. This platform is designed to automatically modify stimulation parameters based on individual patient responses, improving pain management outcomes and reducing the need for frequent in-person programming visits. By incorporating real-time insights and remote management capabilities, HFX iQ seeks to improve treatment precision, streamline clinical workflows, and deliver a more consistent and effective therapy experience for patients with chronic pain.
In November 2023, Boston Scientific Corporation strengthened its chronic pain treatment portfolio by acquiring Relevant Medsystems Inc. for $850 million. This acquisition added basivertebral nerve ablation therapy, provided by Relevant Medsystems, to Boston Scientific's suite of chronic pain solutions, which includes spinal cord stimulation devices. Relevant Medsystems, known for its innovative chronic pain management technologies, enhances Boston Scientific's ability to offer comprehensive treatment options for patients suffering from persistent pain.
Major companies operating in the spinal cord stimulation devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Nevro Corp., Bluewind Medical, NeuroPace Inc., Vertos Medical Inc., SPR Therapeutics Inc., Saluda Medical Pty Ltd., Stimwave Technologies Inc., Nuvectra Inc., Soterix Medical Inc., Synapse Biomedical, ONWARD Medical NV, NeuroSigma Inc., Nalu Medical Inc., Neurostim Technologies, SpineX Inc., Aleva Neurotherapeutics SA, GTX Medical BV.
North America was the largest region in the spinal cord stimulation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spinal cord stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the spinal cord stimulation devices market by increasing costs of electronic components, implantable leads, and battery systems. Implantable and rechargeable device segments are most affected, especially in North America and Europe. However, tariffs have encouraged domestic manufacturing, modular device designs, and supply chain diversification.
The spinal cord stimulation devices market research report is one of a series of new reports that provides spinal cord stimulation devices market statistics, including spinal cord stimulation devices industry global market size, regional shares, competitors with a spinal cord stimulation devices market share, detailed spinal cord stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the spinal cord stimulation devices industry. This spinal cord stimulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Spinal cord stimulation (SCS) devices are implantable medical devices that help manage chronic pain by delivering gentle electrical pulses to the spinal cord. These pulses disrupt pain signals before they reach the brain, providing relief. SCS devices combine advanced neurotechnology with customizable programming, offering a minimally invasive treatment for conditions such as neuropathic pain and failed back surgery syndrome.
The primary types of SCS devices include implantable and non-implantable stimulators. Implantable spinal cord stimulators are surgically placed under the skin and deliver electrical pulses directly to the spinal cord, interfering with pain signals to alleviate chronic discomfort. SCS devices are further categorized into rechargeable and non-rechargeable types. They are used for various applications, including failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease, unsuccessful disk surgery, and other chronic pain conditions. End users include hospitals, ambulatory surgical centers, and neuro clinics.
The spinal cord stimulation devices market consists of sales of implantable pulse generators (IPGs), leads and electrodes, MRI-compatible SCS devices, and hybrid stimulation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Spinal Cord Stimulation Devices Market Characteristics
3. Spinal Cord Stimulation Devices Market Supply Chain Analysis
4. Global Spinal Cord Stimulation Devices Market Trends and Strategies
5. Spinal Cord Stimulation Devices Market Analysis of End Use Industries
7. Global Spinal Cord Stimulation Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Spinal Cord Stimulation Devices Total Addressable Market (TAM) Analysis for the Market
9. Spinal Cord Stimulation Devices Market Segmentation
10. Spinal Cord Stimulation Devices Market Regional and Country Analysis
11. Asia-Pacific Spinal Cord Stimulation Devices Market
12. China Spinal Cord Stimulation Devices Market
13. India Spinal Cord Stimulation Devices Market
14. Japan Spinal Cord Stimulation Devices Market
15. Australia Spinal Cord Stimulation Devices Market
16. Indonesia Spinal Cord Stimulation Devices Market
17. South Korea Spinal Cord Stimulation Devices Market
18. Taiwan Spinal Cord Stimulation Devices Market
19. South East Asia Spinal Cord Stimulation Devices Market
20. Western Europe Spinal Cord Stimulation Devices Market
21. UK Spinal Cord Stimulation Devices Market
22. Germany Spinal Cord Stimulation Devices Market
23. France Spinal Cord Stimulation Devices Market
24. Italy Spinal Cord Stimulation Devices Market
25. Spain Spinal Cord Stimulation Devices Market
26. Eastern Europe Spinal Cord Stimulation Devices Market
27. Russia Spinal Cord Stimulation Devices Market
28. North America Spinal Cord Stimulation Devices Market
29. USA Spinal Cord Stimulation Devices Market
30. Canada Spinal Cord Stimulation Devices Market
31. South America Spinal Cord Stimulation Devices Market
32. Brazil Spinal Cord Stimulation Devices Market
33. Middle East Spinal Cord Stimulation Devices Market
34. Africa Spinal Cord Stimulation Devices Market
36. Spinal Cord Stimulation Devices Market Competitive Landscape and Company Profiles
37. Spinal Cord Stimulation Devices Market Other Major and Innovative Companies
40. Spinal Cord Stimulation Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Spinal Cord Stimulation Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses spinal cord stimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for spinal cord stimulation devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The spinal cord stimulation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Configuration: Implantable Spinal Cord Stimulators; Non-Implantable Spinal Cord Stimulators2) By Product Type: Rechargeable Devices; Non-Rechargeable Devices
3) By Application: Failed Back Surgery Syndrome; Complex Regional Pain Syndrome; Degenerative Disc Disease; Unsuccessful Disk Surgery; Other Applications
4) By End User: Hospitals; Ambulatory Surgical Centers; Neuro Clinics
Subsegments:
1) By Implantable Spinal Cord Stimulators: Rechargeable Spinal Cord Stimulators; Non-Rechargeable Spinal Cord Stimulators; Multi-Lead Implantable Spinal Cord Stimulators2) By Non-Implantable Spinal Cord Stimulators: External Spinal Cord Stimulators; Wearable Spinal Cord Stimulators; Transcutaneous Spinal Cord Stimulators
Companies Mentioned: Abbott Laboratories; Medtronic plc; Boston Scientific Corporation; Nevro Corp.; Bluewind Medical; NeuroPace Inc.; Vertos Medical Inc.; SPR Therapeutics Inc.; Saluda Medical Pty Ltd.; Stimwave Technologies Inc.; Nuvectra Inc.; Soterix Medical Inc.; Synapse Biomedical; ONWARD Medical NV; NeuroSigma Inc.; Nalu Medical Inc.; Neurostim Technologies; SpineX Inc.; Aleva Neurotherapeutics SA; GTX Medical BV
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Spinal Cord Stimulation Devices market report include:- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Nevro Corp.
- Bluewind Medical
- NeuroPace Inc.
- Vertos Medical Inc.
- SPR Therapeutics Inc.
- Saluda Medical Pty Ltd.
- Stimwave Technologies Inc.
- Nuvectra Inc.
- Soterix Medical Inc.
- Synapse Biomedical
- ONWARD Medical NV
- NeuroSigma Inc.
- Nalu Medical Inc.
- Neurostim Technologies
- SpineX Inc.
- Aleva Neurotherapeutics SA
- GTX Medical BV
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 3.23 Billion |
| Forecasted Market Value ( USD | $ 4.47 Billion |
| Compound Annual Growth Rate | 8.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
